ABIO ARCA biopharma, Inc.

2.45
0  -6%
Previous Close 2.60
Open 2.60
Price To book 0.89
Market Cap 22.25M
Shares 9,082,000
Volume 27,082
Short Ratio 5.49
Av. Daily Volume 38,015

SEC filingsSee all SEC filings

  1. 8-K - Current report 17704644
  2. 10-K - Annual report (Section 13 and 15(d), not S-K Item 405) 17704283
  3. 8-K - Current report 17668233
  4. 8-K - Current report 17654842
  5. 8-K - Current report 17623622

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b interim analysis due 3Q 2017.
Gencaro - GENETIC-AF trial
Chronic Heart Failure

Latest News

  1. ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
  2. ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update
  3. ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual Report
  4. ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
  5. ARCA biopharma Announces 175th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial
  6. ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
  7. ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
  8. Anders Hove, MD Joins ARCA biopharma Board of Directors
  9. ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
  10. ARCA biopharma Announces 150th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial
  11. ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
  12. ARCA BIOPHARMA TO PRESENT AT BIOTECH SHOWCASE 2017
  13. ARCA BIOPHARMA TO PRESENT AT BIOTECH SHOWCASE 2017
  14. ARCA biopharma to Present at Biotech Showcase 2017
  15. ARCA BIOPHARMA, INC. Financials
  16. StockNewsNow.com Publishes New SNNLive Video Interview with ARCA biopharma, Inc. Provides Company Overview and Discusses Clinical Development
  17. ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
  18. ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
  19. ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2016 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
  20. ARCA biopharma Announces Third Quarter 2016 Financial Results and Provides Business Update